BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Business

  Allon Therapeutics, Inc. Completes U.S. $10 Million Financing Agreement with Nordic Biotech Entity, Isar Pharma K/S

  November 1, 2010

   · 

  6 min read
• FDA

  Varian Medical Systems Receives 510(k) Clearance for Acuros(R) XB Advanced Dose Calculation Algorithm for Planning Radiotherapy and Radiosurgery

  November 1, 2010

   · 

  2 min read
• Johnson & Johnson and Crucell N.V. Provide Progress Update on Preparations for Public Offer

  November 1, 2010

   · 

  7 min read
• Drug Development

  Phase 2b Study Demonstrates GlobeImmune, Inc.'s GI-5005 HCV Therapeutic Vaccine Increases Sustained Virologic Response by 12 Percent in Patients Who Previously Failed Therapy With Standard of Care

  November 1, 2010

   · 

  4 min read
• Policy

  NuPathe Inc. Submits Zelrix NDA for the Treatment of Migraine

  November 1, 2010

   · 

  6 min read
• BioCapital

  PharmAthene, Inc. Announces Proposed Common Stock Offering

  November 1, 2010

   · 

  3 min read